International Clinical Trial: Effect of Remimazolam on Hypoxemia and/or Hypotension in Prostate Biopsy

Geneva, Oct. 9 -- International Clinical Trials Registry received information related to the study (NCT07854197) titled 'Effect of Remimazolam on Hypoxemia and/or Hypotension in Prostate Biopsy' on Sept. 27.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Other. Masking: Single (Outcomes Assessor).

Primary Sponsor: RenJi Hospital

Condition: Prostate Biopsy Sedation Complication

Intervention: Drug: Using remimazolam for sedation during prostate biopsy

Recruitment Status: Not recruiting

Phase: N/A

Date of First Enrollment: October 8, 2026

Target Sample Size: 1146

To know more, visit https://clinicaltrials.gov/study/NCT07854197

Published by HT Digita...